Bank of Montreal’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-14,819
Closed -$184K – 3869
2025
Q4
$184K Sell
14,819
-298
-2% -$3.96K ﹤0.01% 2876
2025
Q3
$217K Sell
15,117
-4,745
-24% -$65K ﹤0.01% 2727
2025
Q2
$244K Buy
19,862
+9,254
+87% +$134K ﹤0.01% 2690
2025
Q1
$233K Buy
10,608
+2,415
+29% +$56.8K ﹤0.01% 2651
2024
Q4
$186K Buy
8,193
+996
+14% +$21.7K ﹤0.01% 2786
2024
Q3
$129K Sell
7,197
-226,313
-97% -$5.25M ﹤0.01% 3177
2024
Q2
$6.85M Buy
233,510
+224,186
+2,404% +$6.65M ﹤0.01% 1147
2024
Q1
$331K Buy
9,324
+2,166
+30% +$86.6K ﹤0.01% 2719
2023
Q4
$320K Sell
7,158
-178
-2% -$7K ﹤0.01% 2821
2023
Q3
$291K Sell
7,336
-10,027
-58% -$422K ﹤0.01% 2828
2023
Q2
$720K Buy
17,363
+457
+3% +$22K ﹤0.01% 2363
2023
Q1
$971K Buy
16,906
+1,255
+8% +$70.7K ﹤0.01% 2061
2022
Q4
$888K Sell
15,651
-4,278
-21% -$218K ﹤0.01% 2269
2022
Q3
$869K Sell
19,929
-2,337
-10% -$120K ﹤0.01% 2260
2022
Q2
$1.3M Sell
22,266
-236
-1% -$14.2K ﹤0.01% 2151
2022
Q1
$1.48M Sell
22,502
-967
-4% -$63.7K ﹤0.01% 2099
2021
Q4
$1.62M Buy
23,469
+1,130
+5% +$76.5K ﹤0.01% 1688
2021
Q3
$1.58M Sell
22,339
-1,626
-7% -$115K ﹤0.01% 2211
2021
Q2
$1.67M Sell
23,965
-12,342
-34% -$873K ﹤0.01% 2169
2021
Q1
$2.52M Sell
36,307
-15,282
-30% -$1.04M ﹤0.01% 1670
2020
Q4
$3.4M Buy
51,589
+3,539
+7% +$190K ﹤0.01% 1575
2020
Q3
$2.34M Sell
48,050
-10,371
-18% -$493K ﹤0.01% 1600
2020
Q2
$2.71M Buy
58,421
+5,876
+11% +$289K ﹤0.01% 1481
2020
Q1
$2.23M Buy
52,545
+28,877
+122% +$1.52M ﹤0.01% 1383
2019
Q4
$1.38M Buy
23,668
+6,042
+34% +$360K ﹤0.01% 2073
2019
Q3
$1.06M Buy
17,626
+276
+2% +$16.4K ﹤0.01% 2050
2019
Q2
$969K Sell
17,350
-1,414
-8% -$72.8K ﹤0.01% 2080
2019
Q1
$1.04M Buy
18,764
+5,116
+37% +$261K ﹤0.01% 2005
2018
Q4
$616K Sell
13,648
-872
-6% -$47.8K ﹤0.01% 2082
2018
Q3
$956K Sell
14,520
-1,498
-9% -$93.1K ﹤0.01% 2026
2018
Q2
$1.03M Buy
16,018
+5,739
+56% +$355K ﹤0.01% 1992
2018
Q1
$568K Buy
10,279
+1,000
+11% +$52.4K ﹤0.01% 2159
2017
Q4
$444K Buy
9,279
+250
+3% +$12.2K ﹤0.01% 2339
2017
Q3
$456K Buy
9,029
+387
+4% +$19.9K ﹤0.01% 2313
2017
Q2
$470K Hold
8,642
– – ﹤0.01% 2303
2017
Q1
$364K Sell
8,642
-504
-6% -$21.5K ﹤0.01% 2226
2016
Q4
$185K Buy
9,146
+1,554
+20% +$63.2K ﹤0.01% 2527
2016
Q3
$314K Buy
7,592
+1,280
+20% +$53.6K ﹤0.01% 2268
2016
Q2
$252K Sell
6,312
-572
-8% -$20.6K ﹤0.01% 2357
2016
Q1
$231K Buy
6,884
+3,184
+86% +$99.2K ﹤0.01% 2382
2015
Q4
$125K Buy
3,700
+2,300
+164% +$71.9K ﹤0.01% 2663
2015
Q3
$42K Buy
1,400
+309
+28% +$9.66K ﹤0.01% 2992
2015
Q2
$27K Hold
1,091
– – ﹤0.01% 3200
2015
Q1
$27K Hold
1,091
– – ﹤0.01% 3157
2014
Q4
$24K Hold
1,091
– – ﹤0.01% 3309
2014
Q3
$22K Sell
1,091
-1,404
-56% -$27.9K ﹤0.01% 3433
2014
Q2
$48K Buy
2,495
+1,394
+127% +$26K ﹤0.01% 3216
2014
Q1
$21K Sell
1,101
-563
-34% -$10.9K ﹤0.01% 3467
2013
Q4
$32K Buy
1,664
+98
+6% +$1.8K ﹤0.01% 3052
2013
Q3
$26K Sell
1,566
-379
-19% -$6.08K ﹤0.01% 3111
2013
Q2
$29K Buy
+1,945
New +$28.5K ﹤0.01% 2938

Other funds holding IART

Bank of Montreal's IART Position: Q1 2026 in Review

Bank of Montreal sold out of Integra LifeSciences (IART) in Q1 2026, closing a stake of 14,819 shares — an estimated $184K sold.

Bank of Montreal first reported a position in IART in Q2 2013 and held it in 51 quarters. The position peaked at $6.85M in Q2 2024. 202 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Bank of Montreal reported no remaining Integra LifeSciences position as of Q1 2026 after selling out during the quarter.
  • Bank of Montreal sold 14,819 Integra LifeSciences shares in Q1 2026, an estimated $184K.
  • Bank of Montreal first reported a position in Integra LifeSciences in Q2 2013 and held it in 51 quarters.
  • Bank of Montreal's Integra LifeSciences position peaked at $6.85M in Q2 2024.
  • 202 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.